TOP

LOGIN
Medical Services

Medical expertise on top of solid underwriting.
Medical Services
Medical Services
Facultative Underwriting Manuals Knowledge Events Experts

You can rely on our experienced, responsive medical directors. Our team supports Gen Re – and is here for you. 

Supporting Clients

Our medical team and underwriting team work together. The latest medical knowledge with underwriting experience benefits Gen Re clients. 

Facultative Underwriting

Gen Re provides unique solutions for our Fac-only and Automatic clients, helping you improve placement rates, profitability, producer retention, and producer recruiting. The forerunner in assessing elderly risks, Gen Re is a leader among facultative life underwriters. Our solutions include:

  • Increasing speed of the underwriting process
  • A unique approach to underwriter audits which can save significant time
  • Metric-driven automated workflow options to reward your best producers and retain a higher percentage of new producers
  • Customized underwriting requirements for producers
  • Benchmarking EKG requirements
  • Unique Financial Underwriting Requirement bundles
  • Application and Questionnaire design to improve mortality
  • Simplified Underwriting application and requirement design
Facultative Underwriting

Underwriting Manuals

The Gen Re underwriting manuals provide our clients with reliable, up-to-date information to assess risks effectively. Creating and maintaining the manuals are a team of experts dedicated to constantly improving and further developing underwriting guidelines. 

  • In the U.S., our SOURCE underwriting manuals are dynamic risk assessment tools – available for the full range of risks relevant to Individual Life, Individual Disability, and Critical Illness underwriting
  • Custom-SOURCE is available for companies that want control over the content to reflect their own company-specific underwriting guidelines. U.S. Group Life clients enjoy customization on limited duration underwriting.
  • Gen Re’s underwriting manual CLUE supports underwriters across the globe in their daily work by providing comprehensive, evidence-based guidelines for the assessment of multiple types of risk. 

SOURCE

Our underwriting manuals are dynamic risk assessment tools – available for the full range of risks relevant to Individual Life, Individual Disability, and Critical Illness underwriting.

Read More

Custom-SOURCE

This tool is available for companies that want control over the content to reflect their own company-specific underwriting guidelines. Group Life clients enjoy customization on limited duration underwriting.

CLUE

Gen Re’s underwriting manual CLUE supports underwriters by providing comprehensive, evidence-based guidelines for the assessment of multiple types of risk.

Read More
Publication
Remember to Forget – Insuring Cancer Survivors in the EU
Life insurers across Europe are facing new legislative challenges with insuring cancer survivors and their “Right to be Forgotten”. The moves took up speed after “Europe’s Beating Cancer Plan” was published in February 2021. We review different European regulations.
Dr. Åsa Weber December 16, 2022
Read More
Publication
The HIV Pandemic: From a Death Sentence to a Chronic Disease
The article reflects on the HIV/AIDS pandemic journey and on the status quo of the quality of life of people living with HIV(PLHIV). Recent data shows that the mortality rate of PLHIV is decreasing in many countries. Although a HIV cure or vaccine are still scientific challenges, research in this direction is promising.
Dr. Kohar Annie Kissoyan December 1, 2022
Read More
Publication
Just Your Common Flu ...
In early 2020, many assumed COVID-19 would prove to be but a blip compared with the “common flu.” Minimization narratives such as this have long since vanished from the mainstream, but as we grapple with what the world with endemic SARS-CoV-2 looks like,...
Sara Goldberg December 21, 2021
Read More
Publication
Why Are We Still Waiting for a Vaccine for HIV?
In view of the rapid development of a number of vaccines against the SARS-CoV-2 virus, the question has been asked, why we are still awaiting an HIV vaccine?
Dr. John O’Brien November 30, 2021
Read More

Events

Events

Contact Us

Contact us to learn more about how we can help you. 

Supporting the Industry

Learn more about us.